LMWH, unfractionated heparin similar for perioperative thromboprophylaxis

Harris, Jason; Shafer, Emily
July 2008
Hem/Onc Today;7/25/2008, Vol. 9 Issue 13, p27
The article discusses research being done on the postsurgical outcomes associated with low-molecular weight heparin (LMWH) and unfractionated heparin in patients diagnosed with cancer. It references a study published in the 2008 issue of "Archives of Internal Medicine." Study researchers analyzed the results of 14 randomized controlled trials. They found that LMWH and unfractionated heparin demonstrated nearly identical postsurgical outcomes.


Related Articles

  • Antithrombotic Strategies in Patients With Acute Coronary Syndromes Undergoing Early Invasive Management. Stone, Gregg W.; Ware, James H.; Bertrand, Michael E.; Lincoff, A. Michael; Moses, Jeffrey W.; Ohman, E. Magnus; White, Harvey D.; Feit, Frederick; Colombo, Antonio; McLaurin, Brent T.; Cox, David A.; Manoukian, Steven V.; Fahy, Martin; Clayton, Tim C.; Mehran, Roxana; Pocock, Stuart J. // JAMA: Journal of the American Medical Association;12/5/2007, Vol. 298 Issue 21, p2497 

    This article presents the results of follow-ups from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) Trial where moderate and high risk patients with acute coronary syndromes (ACS) underwent early invasive treatment with the thrombin inhibitor bivalirudin or a...

  • Symptomatic and Incidental Venous Thromboembolic Disease Are Both Associated with Mortality in Patients with Prostate Cancer. Chaturvedi, Shruti; Sidana, Surbhi; Elson, Paul; Khorana, Alok A.; McCrae, Keith R. // PLoS ONE;Aug2014, Vol. 9 Issue 8, p1 

    Introduction: The association between malignancy and venous thromboembolic disease (VTE) is well established. The independent impact of VTE, both symptomatic and incidental, on survival in patients with prostate cancer is not known. We conducted a retrospective cohort study to evaluate the...

  • Functional outcomes according to the size of the gastric remnant and type of reconstruction following laparoscopic distal gastrectomy for gastric cancer. Nomura, Eiji; Lee, Sang-Woong; Bouras, George; Tokuhara, Takaya; Hayashi, Michihiro; Hiramatsu, Masako; Okuda, Jyunji; Tanigawa, Nobuhiko // Gastric Cancer;Aug2011, Vol. 14 Issue 3, p279 

    Background: In gastric cancer, various methods of gastric resection and reconstruction have been devised according to the location of the primary tumor and the depth of invasion. The functional outcomes of patients treated by laparoscopy-assisted or totally laparoscopic distal gastrectomy were...

  • Evaluation of a Standardized Protocol Using Lepirudin or Argatroban for Heparin-Induced Thrombocytopenia. Kennedy, Kenneth; Steinke, Doug; King, Shawn; Poe, Kevin; Reeves, Jordan; Short, Marintha // Cardiovascular & Hematological Agents in Medicinal Chemistry;2011, Vol. 9 Issue 4, p262 

    Study Objective: To evaluate the effectiveness of our institution's heparin-induced thrombocytopenia (HIT) protocol in achieving a therapeutic activated partial thromboplastin time (aPTT) and to evaluate patient outcomes related to bleeding and thrombotic events before and after protocol...

  • Optimal Anticoagulation during Off Pump Coronary Artery Bypass in Patients Recently Exposed to Clopidogrel. Young Song; Jong Wook Song; Jae Kwang Shim; Young Lan Kwak // Yonsei Medical Journal;Sep2013, Vol. 54 Issue 5, p1119 

    Purpose: The aim of this study was to find an optimal range of activated clotting time (ACT) during off-pump coronary artery bypass surgery (OPCAB) yielding ischemic protection without the risk of hemorrhagic complications in patients with recent exposure to dual antiplatelet therapy. Materials...

  • Clinical Use of Anti-Xa Monitoring in Malignancy-Associated Thrombosis. Yentz, Sarah; Onwuemene, Oluwatoyosi A.; Stein, Brady L.; Cull, Elizabeth H.; McMahon, Brandon // Thrombosis;10/12/2015, Vol. 2015, p1 

    Introduction. Low molecular weight heparin (LMWH) is preferred for malignancy-associated venous thromboembolism (VTE). Many providers monitor LMWH with anti-Xa levels, despite little validation on correspondence with patient outcome. Methods. This is a retrospective, single institution study of...

  • Apixaban zur Behandlung einer akuten venösen Thromboembolie. Steurer, Johann // Praxis (16618157);10/30/2013, Vol. 102 Issue 22, p1387 

    No abstract available.

  • Continue with heparin until antibody test suggests otherwise.  // PharmacoEconomics & Outcomes News;9/24/2005, Issue 487, p5 

    Discusses research being done on the cost-effectiveness analysis of treatment strategies for heparin-induced thrombocytopenia. Reference to a study conducted by A. R. Patrick, J. Avorn, W. C. Winkelmayer and M. A. Fischer, published in the August 2005 issue of "Pharmacoepidemiology and Drug...

  • Pharmacologic Treatment of Acute Venous Thromboembolism in Patients with Advanced Cancer #236. Claxton, René; Arnold, Robert M. // Journal of Palliative Medicine;Jul2012, Vol. 15 Issue 7, p828 

    The article discusses approach to Venous thromboembolism (VTE), a common complication of malignancy with poor prognosis. It offers evidence supporting use of anticoagulation to decrease mortality and VTE recurrence in patients with a new VTE. It highlights some considerations by clinicians...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics